Sphera Funds Management Ltd. Cti Biopharma Corp Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$1.72 - $5.24 $1.5 Million - $4.58 Million	-874,407 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$3.81 - $5.26 $155,348 - $214,471	40,774 Added 4.89%	874,407 $4.36 Million
Q3 2017 Nov 27, 2017	BUY	$3.12 - $3.65 $2.6 Million - $3.04 Million	833,633	833,633 $2.66 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.